Universal- Beteiligungs- und Servicegesellschaft mbH

Position in EXEL — Exelixis, Inc.

CIK 2057170 FRANKFURT AM MAIN, 2M

Position in EXEL

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$24,600,556

+$3,610,963 QoQ

Shares Held

452,133

-7.6% QoQ

Ownership

0.182%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

#78

of 739 holders

Holding Since

Dec 2024

7 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Universal- Beteiligungs- und Servicegesellschaft mbH holds $732,771,778 across 106 Biotechnology names. EXEL ranks #6 (3.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	323,752	$160,817,330
2	REGN	Regeneron Pharmaceuticals, Inc.	100,286	$62,532,332
3	ALNY	Alnylam Pharmaceuticals, Inc.	157,223	$47,328,839
4	JAZZ	Jazz Pharmaceuticals plc	134,388	$32,383,476
5	INCY	Incyte Corp	236,172	$26,772,457
6	EXEL	Exelixis, Inc. This page	452,133	$24,600,556
7	IONS	Ionis Pharmaceuticals Inc	233,499	$18,514,135
8	PRAX	Praxis Precision Medicines, Inc.	48,118	$16,109,425

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$24,600,556	452,133	-7.6%	Shares	Defined	2026-08-06
2026-03-31	$20,989,593	489,382	-7.7%	Shares	Defined	2026-05-11
2025-12-31	$23,235,159	530,120	+6.7%	Shares	Defined	2026-01-28
2025-09-30	$20,517,468	496,791	+8.6%	Shares	Defined	2025-10-30
2025-06-30	$20,165,057	457,465	+9.1%	Shares	Defined	2025-08-11
2025-03-31	$15,473,836	419,118	+16.3%	Shares	Defined	2025-05-06
2024-12-31	$11,997,723	360,292	—	Shares	Defined	2025-02-28
No filing history on record for this holder in this stock.